Portal de investigación
Genomic profiling in low and intermediate-risk neuroblastoma to refine treatment stratification and improve patient outcome. LINES: a SIOPEN trial (was selected for Fire-session)
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Jiménez, I
- Attignon, V
- Auger, N
- Beiske, K
- Jeison, M
- Martinsson, T
- Masliah-Planchoni, J
- Mazzocco, K
- Mühlethaler-Mottet, A
- Nogueral, R
- van Roy, N
- Trahair, T
- Tweddle, D
- di Cataldo, A
- Papadakis, V
- Wheelers, K
- Taschner-Mandl, S
- Schleiermacher, G
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 2772-610X, 2772-610X
- Tipo:
- Article
- Páginas:
- -
Ejc Paediatric Oncology ELSEVIER
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Cita
Jiménez I,SEGURA V,Attignon V,Auger N,Beiske K,DE MORA JF,Jeison M,Martinsson T,Masliah J,Mazzocco K,Mühlethaler A,Nogueral R,van N,Trahair T,Tweddle D,CANETE A,di A,Papadakis V,Wheelers K,Taschner S,Schleiermacher G. Genomic profiling in low and intermediate-risk neuroblastoma to refine treatment stratification and improve patient outcome. LINES: a SIOPEN trial (was selected for Fire-session). EJC Paediatr. Oncol. 2026. 7. 100429. IF:2,000. (2).